bioRxivMicrobiologyPreprint
Cas12a2 elicits abortive infection via RNA-triggered destruction of double-stranded DNA
O. Dmytrenko, G. Neumann, T. Hallmark, D. J. Keiser, V. M. Crowley, E. Vialetto, I. Mougiakos, K. G. Wandera, H. Domgaard, J. Weber, J. Metcalf, M. B. Begemann, B. N. Gray, R. N. Jackson, C. L. Beisel
Abstract
Bacterial abortive infection systems limit the spread of foreign invaders by shutting down or killing infected cells before the invaders can replicate1, 2. Several RNA-targeting CRISPR-Cas systems (e.g., types III and VI) cause Abi phenotypes by activating indiscriminate RNases3-5. However, a CRISPR-mediated abortive mechanism that relies on indiscriminate DNase activity has yet to be observed. Here we report that RNA targeting by the type V Cas12a2 nuclease drives abortive infection through non-specific cleavage of double-stranded (ds)DNA. Upon recognition of an RNA target with an activating protospacer-flanking sequence, Cas12a2 efficiently degrades single-stranded (ss)RNA, ssDNA, and dsDNA. Within cells, the dsDNase activity induces an SOS response and impairs growth, stemming the infection. Finally, we harnessed the collateral activity of Cas12a2 for direct RNA detection, demonstrating that Cas12a2 can be repurposed as an RNA-guided, RNA-targeting tool. These findings expand the known defensive capabilities of CRISPR-Cas systems and create additional opportunities for CRISPR technologies.
- assay: DNA methylation
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: protein structure prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2
J. P. Bravo, T. Hallmark, … D. W. Taylor·bioRxiv·Jun 13, 2022
- CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity
N. D. Marino, R. Pinilla-Redondo, J. Bondy-Denomy·bioRxiv·Mar 10, 2022
- A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression
C. J. Huang, B. A. Adler, J. A. Doudna·bioRxiv·Dec 6, 2021
- CRISPR-Cas12a target binding unleashes single-stranded DNase activity
J. S. Chen, E. Ma, … J. A. Doudna·bioRxiv·Nov 29, 2017
- Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNA
Sobita Kunwar, Thomson Hallmark, … Ryan N. Jackson·Nucleic Acids ResearchPeer-reviewed·May 28, 2026
- DNA-guided CRISPR/Cas12 for RNA targeting
Carlos Orosco, Santosh R. Rananaware, … Piyush Jain·medRxiv·Nov 21, 2024